|
COPA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.018400E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.599500E-04 |
| Normal-vs-Stage2 |
9.838100E-03 |
| Normal-vs-Stage3 |
2.573200E-04 |
| Normal-vs-Stage4 |
2.802700E-03 |
| Stage1-vs-Stage2 |
9.776400E-01 |
| Stage1-vs-Stage3 |
3.833000E-01 |
| Stage1-vs-Stage4 |
7.819800E-01 |
| Stage2-vs-Stage3 |
5.607200E-01 |
| Stage2-vs-Stage4 |
8.219200E-01 |
| Stage3-vs-Stage4 |
7.311600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.437920E-04 |
| Normal-vs-AfricanAmerican |
5.546400E-01 |
| Normal-vs-Asian |
1.377560E-03 |
| Caucasian-vs-AfricanAmerican |
3.964100E-02 |
| Caucasian-vs-Asian |
8.488400E-01 |
| AfricanAmerican-vs-Asian |
4.747800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.021100E-04 |
| Normal-vs-Female |
3.015800E-04 |
| Male-vs-Female |
6.202400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.202200E-04 |
| Normal-vs-Age(41-60Yrs) |
6.403800E-04 |
| Normal-vs-Age(61-80Yrs) |
1.039410E-03 |
| Normal-vs-Age(81-100Yrs) |
1.253370E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.020200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.646800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.423000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.166000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.520600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.196000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.056100E-02 |
| Classical-VS-Follicular |
2.422400E-02 |
| Classical-VS-Other |
6.885700E-02 |
| Classical-VS-Normal |
5.643000E-03 |
| Tall-VS-Follicular |
7.393600E-01 |
| Tall-VS-Other |
2.936600E-01 |
| Tall-VS-Normal |
2.781200E-04 |
| Follicular-VS-Other |
3.195200E-01 |
| Follicular-VS-Normal |
1.368670E-04 |
| Other-VS-Normal |
3.144300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.592870E-04 |
| Normal-vs-N1 |
5.53829999999644E-05 |
| N0-vs-N1 |
3.762200E-01 |
|
|
